|
"yang wb"的相關文件
顯示項目 1-10 / 26 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2025-07-14 |
Contribution of prostaglandin E2-induced neuronal excitation to drug resistance in glioblastoma countered by a novel blood-brain barrier crossing celecoxib derivative
|
Shen, CJ;Chen, HC;Lin, CL;Thakur, A;Onuku, R;Chen, IC;Li, HY;Chang, KY;Chuang, JY;Yang, WB;Lin, HY;Shen, YR;Liou, JP;Chang, WC;Hsu, TI |
| 國家衛生研究院 |
2025-06-27 |
SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma[Erratum:Journal of Experimental and Clinical Cancer Research. 2022 Jul 13;41:Article number 220.]
|
Chien, CH;Yang, WB;Chuang, JY;Lee, JS;Liao, WA;Huang, CY;Chen, PY;Wu, AC;Yang, ST;Lai, CC;Chi, PI;Chu, JM;Cheng, SM;Liu, CC;Hwang, DY;Chen, SH;Chang, KY |
| 國家衛生研究院 |
2025-01-21 |
Repurposing linezolid in conjunction with histone deacetylase inhibitor access in the realm of glioblastoma therapies
|
Chen, IC;Lin, HY;Liu, ZY;Cheng, WJ;Yeh, TY;Yang, WB;Tran, HY;Lai, MJ;Wang, CH;Kao, TY;Hung, CY;Huang, YL;Liou, KC;Hsieh, CM;Hsu, T;Liou, JP |
| 國家衛生研究院 |
2024-08-06 |
Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma
|
Chen, HC;Lin, HY;Chiang, YH;Yang, WB;Wang, CH;Yang, PY;Hu, SL;Hsu, T |
| 國家衛生研究院 |
2024-06-19 |
CXCR7 activation evokes the anti-PD-L1 antibody against glioblastoma by remodeling CXCL12-mediated immunity
|
Liu, CC;Yang, WB;Chien, CH;Wu, CL;Chuang, JY;Chen, PY;Chu, JM;Cheng, SM;Qiu, LY;Chang, YC;Hwang, DY;Huang, CY;Lee, JS;Chang, KY |
| 國家衛生研究院 |
2024-04-01 |
Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress
|
Sharma, R;Chiang, YH;Chen, HC;Lin, HY;Yang, WB;Nepali, K;Lai, MJ;Chen, KY;Liou, JP;Hsu, TI |
| 國家衛生研究院 |
2024-01-29 |
First-in-class dual EZH2-HSP90 inhibitor eliciting striking antiglioblastoma activity in vitro and in vivo
|
Sharma, S;Wang, SA;Yang, WB;Lin, HY;Lai, MJ;Chen, HC;Kao, TY;Hsu, FL;Nepali, K;Hsu, TI;Liou, JP |
| 國家衛生研究院 |
2023-08-03 |
Dysregulated lipid metabolism in TMZ-resistant glioblastoma: Pathways, proteins, metabolites and therapeutic opportunities
|
Kao, TJ;Lin, CL;Yang, WB;Li, HY;Hsu, TI |
| 國家衛生研究院 |
2022-08-18 |
CCAAT/enhancer-binding protein delta regulates glioblastoma survival through catalase-mediated hydrogen peroxide clearance
|
Lin, HY;Lim, SW;Hsu, TI;Yang, WB;Huang, CC;Tsai, YT;Chang, WC;Ko, CY |
| 國家衛生研究院 |
2022-07-13 |
SH3GLB1-related autophagy mediates mitochondrial metabolism to acquire resistance against temozolomide in glioblastoma
|
Chien, CH;Yang, WB;Chuang, JY;Lee, JS;Liao, WA;Huang, CY;Chen, PY;Wu, AC;Yang, ST;Lai, CC;Chi, PI;Chu, JM;Cheng, SM;Liu, CC;Hwang, DY;Chen, SH;Chang, KY |
顯示項目 1-10 / 26 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
